SCHEMBL30679386

SCHEMBL30679386

CC(C)c1ccnnc1Cl

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GCGR P47871 1/20 0.30
LMNA P02545 2/20 0.30
FAAH O00519 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
GABRG2 P18507 1/20 0.30
PTGS1 P23219 1/20 0.30
SLC6A2 P23975 1/20 0.30
HTR2C P28335 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
HTR2B P41595 1/20 0.30
GABRA2 P47869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24869040 1.00 GABRA1 (0.32) GABRA1GABRB1GCGRLMNAFAAH
SCHEMBL2894499 0.83 LMNA (0.39) LMNACYP1A2CYP3A4
SCHEMBL27692396 0.79
SCHEMBL27673817 0.79
SCHEMBL10079968 0.78
SCHEMBL4546364 0.74 GABRA1 (0.31) GABRA1GABRB1LMNAFAAHCA1
SCHEMBL10297516 0.74 LMNA (0.31) GABRA1GABRB1LMNAFAAHCA1
SCHEMBL14943106 0.74 RPS6KA3 (0.36) GABRA1GABRB1LMNAFAAHCA1
SCHEMBL8505132 0.74 ADRA2A (0.37) LMNACYP1A2CYP3A4HPGDTSHR
SCHEMBL27673765 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568948-A1 COMPOUNDS FOR TREATING CANCER Genesis Therapeutics, Inc. (US) 2025-06-18 EP disclosed
WO-2024059010-A1 COMPOUNDS FOR TREATING CANCER GENESIS THERAPEUTICS, INC. (US) 2024-03-21 WO disclosed
EP-4291176-A1 CDK INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2023-12-20 EP disclosed